- Home
- MNKD vs DRH Comparison
MNKD vs DRH Comparison
Compare MNKD & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- DRH
- Stock Information
- Founded
- MNKD 1991
- DRH 2004
- Country
- MNKD United States
- DRH United States
- Employees
- MNKD N/A
- DRH N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- DRH Real Estate Investment Trusts
- Sector
- MNKD Health Care
- DRH Real Estate
- Exchange
- MNKD Nasdaq
- DRH Nasdaq
- Market Cap
- MNKD 1.4B
- DRH 1.6B
- IPO Year
- MNKD 2004
- DRH 2005
- Fundamental
- Price
- MNKD $3.77
- DRH $7.62
- Analyst Decision
- MNKD Buy
- DRH Hold
- Analyst Count
- MNKD 4
- DRH 6
- Target Price
- MNKD $9.75
- DRH $8.79
- AVG Volume (30 Days)
- MNKD 2.6M
- DRH 2.9M
- Earning Date
- MNKD 08-06-2025
- DRH 08-07-2025
- Dividend Yield
- MNKD N/A
- DRH 5.51%
- EPS Growth
- MNKD 228.27
- DRH N/A
- EPS
- MNKD 0.10
- DRH 0.19
- Revenue
- MNKD $297,595,000.00
- DRH $1,128,313,000.00
- Revenue This Year
- MNKD $13.72
- DRH N/A
- Revenue Next Year
- MNKD $15.21
- DRH $2.13
- P/E Ratio
- MNKD $36.35
- DRH $40.08
- Revenue Growth
- MNKD 32.50
- DRH 3.73
- 52 Week Low
- MNKD $3.63
- DRH $6.19
- 52 Week High
- MNKD $7.63
- DRH $10.00
- Technical
- Relative Strength Index (RSI)
- MNKD 34.62
- DRH 50.47
- Support Level
- MNKD $3.63
- DRH $7.47
- Resistance Level
- MNKD $3.85
- DRH $7.93
- Average True Range (ATR)
- MNKD 0.15
- DRH 0.18
- MACD
- MNKD -0.02
- DRH -0.01
- Stochastic Oscillator
- MNKD 16.47
- DRH 41.51
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.